Research

Germline mutations can contribute to leukemia, retinoblastoma, and other pediatric cancers. Learn about advancements in the first landmark effort specifically designed to better understand these mutations and develop novel treatment methods.

Because of St. Jude Cloud, terabytes of pediatric cancer genomic data can now be readily accessed, analyzed and visualized.

Dr. Josh Wolf explains how biostatistics resolved safety questions on preemptive vancomycin for acute myeloid leukemia patients after chemotherapy.

Many adolescents fail to get a key vaccination that can prevent cancer. Learn what doctors know about the HPV cancer vaccine.

The most important part of research is that you must not fool yourself — and you’re the easiest person to fool.

Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.

Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.

Jun J. Yang, PhD, shares research presented at ASH that highlights the role the GATA3 oncogene plays in a high-risk subset of acute lymphoblastic leukemia.

Jun J. Yang, PhD, offers highlights of the first ALL session at the American Society of Hematology (ASH) meeting, including his work on TP53. Read more.

Find out how a researcher applied statistical analysis to chart variance and better understand how childhood leukemia develops.